Ann: Latest R&D Funding Received & Further Drawdown from Lind, page-2

How many $'s are left?
From my rough calculation from the last 1/4's cash flow report 1/8/18 using their cash on hand and the estimated cash outflows and then including the two "Pleased to advise" $3mill from Brevet and $1.95 mil from lind.
All added together it would not have added up to their estimated cash outflows for the 1/4.

Now it was handy that when they changed tact to a pilot plant, it fitted into the R&D rebates of 43.5%
But as George B has said the proposed budget changes to R&D projects could limit returns in the 18/19 year to $4,000,000.  I estimate that the R&D returns on the 17/18 year were about $22,375,000 of which $17,900,000 had to be returned to Brevet.

And lets not forget the $8.1 million indigenous training-to-work facility. Where is it?

And also the sales agreement early payment of $10,000,000.  When they are talking about first shipment end of September I guess this payment would be not far off.

And as George said earlier in the year (post 33044518 ) in relation to key risks going forward, he said it was going to be the price of Dysprosium and Terbium in July, and now add to that the chance of R&D rebate change.

capital raise soon???

I await and see what the next ASX Ann good news story will be. Price Sen no doubt.


.